The IQ Consortium marks a decade of impactful innovation of collaboration through a network of pharmaceutical companies driving change for the bio/pharmaceutical industry.
Pierre Boulas
Advertisement
Pierre Boulas is executive director, Product and Technology Development, Biogen.
Articles by Pierre Boulas
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Alvotech, Advanz Submit First Eylea 8 mg Biosimilar Bid
2
Lilly's Mirikizumab (Omvoh) Hits New IBD Remission Goals
3
Shift to In Vivo CAR T Will Reshape Facility Design, Says Arcadis’ Emily Heffernan
4
FDA Accepts BLA for Formycon and Zydus’ FYB206, the First Publicly Announced Keytruda Biosimilar Under Review
5